Medical implants sometimes fail due to scarring. UVA biomedical engineering researchers found specific cells are likely to blame, which could lead to new biomaterial designs that improve patient outcomes.

Researchers describe the full molecular structure of the phage DEV. DEV infects and lyses Pseudomonas aeruginosa bacteria, an opportunistic pathogen in cystic fibrosis and other diseases. DEV is part of an experimental phage cocktail developed to eradicate P. aeruginosa infection in pre-clinical studies.

Cutting off cancer cells’ access to fat may help a specific type of cancer treatment work more effectively, reports a study by Van Andel Institute scientists. The findings, published in Cell Chemical Biology, lay the groundwork for developing tailored dietary strategies to help anti-cancer medications better kill malignant cells.